nodes	percent_of_prediction	percent_of_DWPC	metapath
Ioflupane I 123—Cocaine—SCN10A—breast cancer	0.0138	0.637	CrCbGaD
Ioflupane I 123—SLC6A3—Clearance of dopamine—COMT—breast cancer	0.0131	0.103	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—breast cancer	0.00856	0.0672	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—breast cancer	0.00746	0.0585	CbGpPWpGaD
Ioflupane I 123—Neoplasm malignant—Gemcitabine—breast cancer	0.00671	0.00789	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Fluoxymesterone—breast cancer	0.00636	0.00747	CcSEcCtD
Ioflupane I 123—Immune system disorder—Exemestane—breast cancer	0.00622	0.00731	CcSEcCtD
Ioflupane I 123—Vertigo—Fulvestrant—breast cancer	0.0062	0.00729	CcSEcCtD
Ioflupane I 123—Increased appetite—Goserelin—breast cancer	0.00616	0.00723	CcSEcCtD
Ioflupane I 123—Vertigo—Toremifene—breast cancer	0.00612	0.0072	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Lapatinib—breast cancer	0.00601	0.00706	CcSEcCtD
Ioflupane I 123—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—breast cancer	0.00596	0.0468	CbGpPWpGaD
Ioflupane I 123—Immune system disorder—Ixabepilone—breast cancer	0.00587	0.0069	CcSEcCtD
Ioflupane I 123—Malnutrition—Ixabepilone—breast cancer	0.00566	0.00665	CcSEcCtD
Ioflupane I 123—Pain—Carboplatin—breast cancer	0.00556	0.00653	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Fulvestrant—breast cancer	0.00553	0.00649	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Toremifene—breast cancer	0.00545	0.00641	CcSEcCtD
Ioflupane I 123—Headache—Fluoxymesterone—breast cancer	0.00541	0.00635	CcSEcCtD
Ioflupane I 123—Malnutrition—Letrozole—breast cancer	0.00533	0.00626	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Lapatinib—breast cancer	0.00529	0.00622	CcSEcCtD
Ioflupane I 123—Immune system disorder—Idarubicin—breast cancer	0.00525	0.00617	CcSEcCtD
Ioflupane I 123—Dysgeusia—Letrozole—breast cancer	0.00522	0.00613	CcSEcCtD
Ioflupane I 123—Dysgeusia—Anastrozole—breast cancer	0.00522	0.00613	CcSEcCtD
Ioflupane I 123—Nausea—Fluoxymesterone—breast cancer	0.00513	0.00602	CcSEcCtD
Ioflupane I 123—Paraesthesia—Fulvestrant—breast cancer	0.00506	0.00595	CcSEcCtD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—ALDH1A1—breast cancer	0.00506	0.0397	CbGpPWpGaD
Ioflupane I 123—Malnutrition—Idarubicin—breast cancer	0.00506	0.00594	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Fulvestrant—breast cancer	0.00486	0.00572	CcSEcCtD
Ioflupane I 123—Injection site pain—Capecitabine—breast cancer	0.00482	0.00567	CcSEcCtD
Ioflupane I 123—Pain—Fulvestrant—breast cancer	0.00482	0.00566	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Toremifene—breast cancer	0.0048	0.00564	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Exemestane—breast cancer	0.0048	0.00564	CcSEcCtD
Ioflupane I 123—Vertigo—Letrozole—breast cancer	0.00479	0.00563	CcSEcCtD
Ioflupane I 123—Pain—Toremifene—breast cancer	0.00476	0.00559	CcSEcCtD
Ioflupane I 123—Vertigo—Raloxifene—breast cancer	0.00454	0.00534	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Ixabepilone—breast cancer	0.00453	0.00532	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Lapatinib—breast cancer	0.00451	0.00531	CcSEcCtD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—GLI2—breast cancer	0.00451	0.0354	CbGpPWpGaD
Ioflupane I 123—Dry mouth—Letrozole—breast cancer	0.00444	0.00521	CcSEcCtD
Ioflupane I 123—Dry mouth—Anastrozole—breast cancer	0.00444	0.00521	CcSEcCtD
Ioflupane I 123—Paraesthesia—Exemestane—breast cancer	0.00439	0.00516	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Letrozole—breast cancer	0.00426	0.00501	CcSEcCtD
Ioflupane I 123—Cocaine—CYP2D6—breast cancer	0.00425	0.196	CrCbGaD
Ioflupane I 123—Gastrointestinal disorder—Exemestane—breast cancer	0.00423	0.00497	CcSEcCtD
Ioflupane I 123—Pain—Exemestane—breast cancer	0.00419	0.00492	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Fulvestrant—breast cancer	0.00415	0.00488	CcSEcCtD
Ioflupane I 123—Paraesthesia—Ixabepilone—breast cancer	0.00415	0.00487	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Raloxifene—breast cancer	0.00405	0.00476	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Ixabepilone—breast cancer	0.00399	0.00469	CcSEcCtD
Ioflupane I 123—Pain—Ixabepilone—breast cancer	0.00395	0.00464	CcSEcCtD
Ioflupane I 123—Paraesthesia—Letrozole—breast cancer	0.0039	0.00459	CcSEcCtD
Ioflupane I 123—Paraesthesia—Anastrozole—breast cancer	0.0039	0.00459	CcSEcCtD
Ioflupane I 123—Headache—Lapatinib—breast cancer	0.00384	0.00451	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Letrozole—breast cancer	0.00375	0.00441	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Anastrozole—breast cancer	0.00375	0.00441	CcSEcCtD
Ioflupane I 123—Dizziness—Fulvestrant—breast cancer	0.00373	0.00438	CcSEcCtD
Ioflupane I 123—Pain—Anastrozole—breast cancer	0.00372	0.00437	CcSEcCtD
Ioflupane I 123—Pain—Letrozole—breast cancer	0.00372	0.00437	CcSEcCtD
Ioflupane I 123—Immune system disorder—Melphalan—breast cancer	0.0037	0.00435	CcSEcCtD
Ioflupane I 123—Dizziness—Toremifene—breast cancer	0.00368	0.00432	CcSEcCtD
Ioflupane I 123—Cocaine—CYP3A4—breast cancer	0.00364	0.168	CrCbGaD
Ioflupane I 123—Nausea—Lapatinib—breast cancer	0.00364	0.00428	CcSEcCtD
Ioflupane I 123—Immune system disorder—Goserelin—breast cancer	0.00361	0.00425	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Exemestane—breast cancer	0.00361	0.00424	CcSEcCtD
Ioflupane I 123—Dysgeusia—Tamoxifen—breast cancer	0.00357	0.0042	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Raloxifene—breast cancer	0.00356	0.00419	CcSEcCtD
Ioflupane I 123—Headache—Fulvestrant—breast cancer	0.00353	0.00415	CcSEcCtD
Ioflupane I 123—Pain—Raloxifene—breast cancer	0.00353	0.00415	CcSEcCtD
Ioflupane I 123—Headache—Toremifene—breast cancer	0.00348	0.00409	CcSEcCtD
Ioflupane I 123—Malnutrition—Goserelin—breast cancer	0.00348	0.00409	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Ixabepilone—breast cancer	0.0034	0.004	CcSEcCtD
Ioflupane I 123—Vertigo—Vinblastine—breast cancer	0.00337	0.00396	CcSEcCtD
Ioflupane I 123—Injection site pain—Epirubicin—breast cancer	0.00336	0.00395	CcSEcCtD
Ioflupane I 123—Nausea—Fulvestrant—breast cancer	0.00335	0.00393	CcSEcCtD
Ioflupane I 123—Nausea—Toremifene—breast cancer	0.0033	0.00388	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.0033	0.0259	CbGpPWpGaD
Ioflupane I 123—Immune system disorder—Vinorelbine—breast cancer	0.00324	0.0038	CcSEcCtD
Ioflupane I 123—Dizziness—Exemestane—breast cancer	0.00324	0.0038	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Epirubicin—breast cancer	0.00321	0.00378	CcSEcCtD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—WNT1—breast cancer	0.00321	0.0252	CbGpPWpGaD
Ioflupane I 123—Hypersensitivity—Anastrozole—breast cancer	0.0032	0.00377	CcSEcCtD
Ioflupane I 123—Malnutrition—Vinorelbine—breast cancer	0.00312	0.00367	CcSEcCtD
Ioflupane I 123—Injection site pain—Doxorubicin—breast cancer	0.00311	0.00365	CcSEcCtD
Ioflupane I 123—Immune system disorder—Thiotepa—breast cancer	0.00309	0.00363	CcSEcCtD
Ioflupane I 123—Headache—Exemestane—breast cancer	0.00307	0.0036	CcSEcCtD
Ioflupane I 123—Dizziness—Ixabepilone—breast cancer	0.00305	0.00359	CcSEcCtD
Ioflupane I 123—Increased appetite—Capecitabine—breast cancer	0.00304	0.00358	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Idarubicin—breast cancer	0.00304	0.00357	CcSEcCtD
Ioflupane I 123—Dry mouth—Tamoxifen—breast cancer	0.00304	0.00357	CcSEcCtD
Ioflupane I 123—Malnutrition—Thiotepa—breast cancer	0.00298	0.0035	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Doxorubicin—breast cancer	0.00297	0.00349	CcSEcCtD
Ioflupane I 123—Nausea—Exemestane—breast cancer	0.00291	0.00342	CcSEcCtD
Ioflupane I 123—Dry mouth—Goserelin—breast cancer	0.0029	0.00341	CcSEcCtD
Ioflupane I 123—Headache—Ixabepilone—breast cancer	0.00289	0.0034	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Chlorambucil—breast cancer	0.00289	0.00339	CcSEcCtD
Ioflupane I 123—Dizziness—Anastrozole—breast cancer	0.00288	0.00338	CcSEcCtD
Ioflupane I 123—Dizziness—Letrozole—breast cancer	0.00288	0.00338	CcSEcCtD
Ioflupane I 123—Pain—Chlorambucil—breast cancer	0.00286	0.00336	CcSEcCtD
Ioflupane I 123—SLC6A3—Monoamine Transport—ACHE—breast cancer	0.00282	0.0222	CbGpPWpGaD
Ioflupane I 123—Vertigo—Vinorelbine—breast cancer	0.0028	0.00329	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Goserelin—breast cancer	0.00279	0.00328	CcSEcCtD
Ioflupane I 123—Paraesthesia—Vinblastine—breast cancer	0.00275	0.00323	CcSEcCtD
Ioflupane I 123—Nausea—Ixabepilone—breast cancer	0.00274	0.00322	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00274	0.0215	CbGpPWpGaD
Ioflupane I 123—Dizziness—Raloxifene—breast cancer	0.00273	0.00321	CcSEcCtD
Ioflupane I 123—Headache—Letrozole—breast cancer	0.00272	0.0032	CcSEcCtD
Ioflupane I 123—Headache—Anastrozole—breast cancer	0.00272	0.0032	CcSEcCtD
Ioflupane I 123—Paraesthesia—Tamoxifen—breast cancer	0.00267	0.00314	CcSEcCtD
Ioflupane I 123—Immune system disorder—Irinotecan—breast cancer	0.00267	0.00314	CcSEcCtD
Ioflupane I 123—Pain—Vinblastine—breast cancer	0.00262	0.00308	CcSEcCtD
Ioflupane I 123—Paraesthesia—Melphalan—breast cancer	0.00262	0.00308	CcSEcCtD
Ioflupane I 123—Immune system disorder—Gemcitabine—breast cancer	0.0026	0.00306	CcSEcCtD
Ioflupane I 123—Headache—Raloxifene—breast cancer	0.00259	0.00304	CcSEcCtD
Ioflupane I 123—Headache—Idarubicin—breast cancer	0.00259	0.00304	CcSEcCtD
Ioflupane I 123—Nausea—Anastrozole—breast cancer	0.00258	0.00304	CcSEcCtD
Ioflupane I 123—Nausea—Letrozole—breast cancer	0.00258	0.00304	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Tamoxifen—breast cancer	0.00257	0.00302	CcSEcCtD
Ioflupane I 123—Paraesthesia—Goserelin—breast cancer	0.00255	0.003	CcSEcCtD
Ioflupane I 123—Pain—Tamoxifen—breast cancer	0.00254	0.00299	CcSEcCtD
Ioflupane I 123—Dysgeusia—Mitoxantrone—breast cancer	0.00252	0.00296	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Melphalan—breast cancer	0.00252	0.00296	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.0025	0.0196	CbGpPWpGaD
Ioflupane I 123—Nervous system disorder—Vinorelbine—breast cancer	0.0025	0.00293	CcSEcCtD
Ioflupane I 123—Pain—Melphalan—breast cancer	0.00249	0.00293	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Chlorambucil—breast cancer	0.00246	0.00289	CcSEcCtD
Ioflupane I 123—Nausea—Raloxifene—breast cancer	0.00245	0.00288	CcSEcCtD
Ioflupane I 123—Nausea—Idarubicin—breast cancer	0.00245	0.00288	CcSEcCtD
Ioflupane I 123—Pain—Goserelin—breast cancer	0.00243	0.00286	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00241	0.0189	CbGpPWpGaD
Ioflupane I 123—Nervous system disorder—Thiotepa—breast cancer	0.00238	0.0028	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A10—breast cancer	0.00238	0.0187	CbGpPWpGaD
Ioflupane I 123—Vertigo—Irinotecan—breast cancer	0.00231	0.00272	CcSEcCtD
Ioflupane I 123—SLC6A3—Parkinsons Disease Pathway—CASP7—breast cancer	0.00229	0.018	CbGpPWpGaD
Ioflupane I 123—Paraesthesia—Vinorelbine—breast cancer	0.00229	0.00269	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Vinblastine—breast cancer	0.00226	0.00265	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—ALDH3A1—breast cancer	0.00221	0.0174	CbGpPWpGaD
Ioflupane I 123—Gastrointestinal disorder—Vinorelbine—breast cancer	0.0022	0.00258	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Tamoxifen—breast cancer	0.00219	0.00258	CcSEcCtD
Ioflupane I 123—Paraesthesia—Thiotepa—breast cancer	0.00218	0.00257	CcSEcCtD
Ioflupane I 123—Pain—Vinorelbine—breast cancer	0.00218	0.00256	CcSEcCtD
Ioflupane I 123—Immune system disorder—Paclitaxel—breast cancer	0.00218	0.00256	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Melphalan—breast cancer	0.00215	0.00252	CcSEcCtD
Ioflupane I 123—Increased appetite—Epirubicin—breast cancer	0.00212	0.00249	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Thiotepa—breast cancer	0.0021	0.00247	CcSEcCtD
Ioflupane I 123—Malnutrition—Paclitaxel—breast cancer	0.0021	0.00247	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Goserelin—breast cancer	0.00209	0.00246	CcSEcCtD
Ioflupane I 123—Pain—Thiotepa—breast cancer	0.00208	0.00244	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00207	0.0163	CbGpPWpGaD
Ioflupane I 123—Nervous system disorder—Irinotecan—breast cancer	0.00206	0.00242	CcSEcCtD
Ioflupane I 123—Dysgeusia—Paclitaxel—breast cancer	0.00205	0.00241	CcSEcCtD
Ioflupane I 123—Dizziness—Vinblastine—breast cancer	0.00203	0.00238	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Gemcitabine—breast cancer	0.00201	0.00236	CcSEcCtD
Ioflupane I 123—Nausea—Chlorambucil—breast cancer	0.00199	0.00233	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC39A7—breast cancer	0.00197	0.0155	CbGpPWpGaD
Ioflupane I 123—Nervous system disorder—Fluorouracil—breast cancer	0.00197	0.00232	CcSEcCtD
Ioflupane I 123—Dizziness—Tamoxifen—breast cancer	0.00197	0.00231	CcSEcCtD
Ioflupane I 123—Increased appetite—Doxorubicin—breast cancer	0.00196	0.00231	CcSEcCtD
Ioflupane I 123—Headache—Vinblastine—breast cancer	0.00192	0.00226	CcSEcCtD
Ioflupane I 123—Paraesthesia—Irinotecan—breast cancer	0.00189	0.00222	CcSEcCtD
Ioflupane I 123—Paraesthesia—Mitoxantrone—breast cancer	0.00189	0.00222	CcSEcCtD
Ioflupane I 123—Vertigo—Paclitaxel—breast cancer	0.00188	0.00222	CcSEcCtD
Ioflupane I 123—Dizziness—Goserelin—breast cancer	0.00188	0.00221	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Vinorelbine—breast cancer	0.00188	0.0022	CcSEcCtD
Ioflupane I 123—Headache—Tamoxifen—breast cancer	0.00186	0.00219	CcSEcCtD
Ioflupane I 123—Immune system disorder—Docetaxel—breast cancer	0.00185	0.00217	CcSEcCtD
Ioflupane I 123—Paraesthesia—Gemcitabine—breast cancer	0.00184	0.00216	CcSEcCtD
Ioflupane I 123—Nausea—Vinblastine—breast cancer	0.00182	0.00214	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Irinotecan—breast cancer	0.00181	0.00213	CcSEcCtD
Ioflupane I 123—Paraesthesia—Fluorouracil—breast cancer	0.00181	0.00212	CcSEcCtD
Ioflupane I 123—Pain—Irinotecan—breast cancer	0.0018	0.00211	CcSEcCtD
Ioflupane I 123—Pain—Mitoxantrone—breast cancer	0.0018	0.00211	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Thiotepa—breast cancer	0.00179	0.00211	CcSEcCtD
Ioflupane I 123—Immune system disorder—Capecitabine—breast cancer	0.00179	0.0021	CcSEcCtD
Ioflupane I 123—Headache—Goserelin—breast cancer	0.00178	0.00209	CcSEcCtD
Ioflupane I 123—Malnutrition—Docetaxel—breast cancer	0.00178	0.00209	CcSEcCtD
Ioflupane I 123—Nausea—Tamoxifen—breast cancer	0.00177	0.00208	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Gemcitabine—breast cancer	0.00177	0.00208	CcSEcCtD
Ioflupane I 123—Pain—Gemcitabine—breast cancer	0.00175	0.00206	CcSEcCtD
Ioflupane I 123—Dry mouth—Paclitaxel—breast cancer	0.00175	0.00205	CcSEcCtD
Ioflupane I 123—Dysgeusia—Docetaxel—breast cancer	0.00174	0.00205	CcSEcCtD
Ioflupane I 123—SLC6A3—Neuronal System—KCNN4—breast cancer	0.00174	0.0137	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A5—breast cancer	0.00174	0.0136	CbGpPWpGaD
Ioflupane I 123—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00174	0.00204	CcSEcCtD
Ioflupane I 123—Nausea—Melphalan—breast cancer	0.00173	0.00203	CcSEcCtD
Ioflupane I 123—Malnutrition—Capecitabine—breast cancer	0.00172	0.00202	CcSEcCtD
Ioflupane I 123—Pain—Fluorouracil—breast cancer	0.00172	0.00202	CcSEcCtD
Ioflupane I 123—Nausea—Goserelin—breast cancer	0.00169	0.00198	CcSEcCtD
Ioflupane I 123—Dysgeusia—Capecitabine—breast cancer	0.00169	0.00198	CcSEcCtD
Ioflupane I 123—Dizziness—Vinorelbine—breast cancer	0.00168	0.00198	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Paclitaxel—breast cancer	0.00168	0.00197	CcSEcCtD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00164	0.0129	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Parkinsons Disease Pathway—CCNE1—breast cancer	0.00161	0.0127	CbGpPWpGaD
Ioflupane I 123—Dizziness—Thiotepa—breast cancer	0.00161	0.00189	CcSEcCtD
Ioflupane I 123—Headache—Vinorelbine—breast cancer	0.00159	0.00187	CcSEcCtD
Ioflupane I 123—Vertigo—Capecitabine—breast cancer	0.00155	0.00182	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Mitoxantrone—breast cancer	0.00155	0.00182	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Irinotecan—breast cancer	0.00155	0.00182	CcSEcCtD
Ioflupane I 123—Paraesthesia—Paclitaxel—breast cancer	0.00154	0.00181	CcSEcCtD
Ioflupane I 123—Headache—Thiotepa—breast cancer	0.00152	0.00179	CcSEcCtD
Ioflupane I 123—Nausea—Vinorelbine—breast cancer	0.00151	0.00178	CcSEcCtD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.0015	0.0118	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.0015	0.0118	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC39A6—breast cancer	0.0015	0.0117	CbGpPWpGaD
Ioflupane I 123—Hypersensitivity—Fluorouracil—breast cancer	0.00148	0.00174	CcSEcCtD
Ioflupane I 123—Dry mouth—Docetaxel—breast cancer	0.00148	0.00174	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Paclitaxel—breast cancer	0.00148	0.00174	CcSEcCtD
Ioflupane I 123—Pain—Paclitaxel—breast cancer	0.00146	0.00172	CcSEcCtD
Ioflupane I 123—Nausea—Thiotepa—breast cancer	0.00144	0.0017	CcSEcCtD
Ioflupane I 123—Dry mouth—Capecitabine—breast cancer	0.00143	0.00168	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Docetaxel—breast cancer	0.00142	0.00167	CcSEcCtD
Ioflupane I 123—Dizziness—Irinotecan—breast cancer	0.00139	0.00163	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Capecitabine—breast cancer	0.00138	0.00162	CcSEcCtD
Ioflupane I 123—Immune system disorder—Methotrexate—breast cancer	0.00133	0.00156	CcSEcCtD
Ioflupane I 123—Dizziness—Fluorouracil—breast cancer	0.00133	0.00156	CcSEcCtD
Ioflupane I 123—Headache—Mitoxantrone—breast cancer	0.00132	0.00155	CcSEcCtD
Ioflupane I 123—Headache—Irinotecan—breast cancer	0.00132	0.00155	CcSEcCtD
Ioflupane I 123—Paraesthesia—Docetaxel—breast cancer	0.0013	0.00153	CcSEcCtD
Ioflupane I 123—Malnutrition—Methotrexate—breast cancer	0.00128	0.00151	CcSEcCtD
Ioflupane I 123—Headache—Gemcitabine—breast cancer	0.00128	0.00151	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTA3—breast cancer	0.00127	0.00998	CbGpPWpGaD
Ioflupane I 123—Paraesthesia—Capecitabine—breast cancer	0.00126	0.00148	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Paclitaxel—breast cancer	0.00126	0.00148	CcSEcCtD
Ioflupane I 123—Headache—Fluorouracil—breast cancer	0.00126	0.00148	CcSEcCtD
Ioflupane I 123—Dysgeusia—Methotrexate—breast cancer	0.00126	0.00148	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Docetaxel—breast cancer	0.00125	0.00147	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.00125	0.00979	CbGpPWpGaD
Ioflupane I 123—Nausea—Mitoxantrone—breast cancer	0.00125	0.00147	CcSEcCtD
Ioflupane I 123—Nausea—Irinotecan—breast cancer	0.00125	0.00147	CcSEcCtD
Ioflupane I 123—Immune system disorder—Epirubicin—breast cancer	0.00124	0.00146	CcSEcCtD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.00124	0.00976	CbGpPWpGaD
Ioflupane I 123—Pain—Docetaxel—breast cancer	0.00124	0.00146	CcSEcCtD
Ioflupane I 123—Nausea—Gemcitabine—breast cancer	0.00121	0.00143	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Capecitabine—breast cancer	0.00121	0.00143	CcSEcCtD
Ioflupane I 123—Pain—Capecitabine—breast cancer	0.0012	0.00141	CcSEcCtD
Ioflupane I 123—Malnutrition—Epirubicin—breast cancer	0.0012	0.00141	CcSEcCtD
Ioflupane I 123—Nausea—Fluorouracil—breast cancer	0.00119	0.0014	CcSEcCtD
Ioflupane I 123—Dysgeusia—Epirubicin—breast cancer	0.00117	0.00138	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTA4—breast cancer	0.00116	0.00912	CbGpPWpGaD
Ioflupane I 123—Immune system disorder—Doxorubicin—breast cancer	0.00115	0.00135	CcSEcCtD
Ioflupane I 123—Vertigo—Methotrexate—breast cancer	0.00115	0.00135	CcSEcCtD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.00114	0.00892	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—GPX2—breast cancer	0.00113	0.00889	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTA2—breast cancer	0.00113	0.00889	CbGpPWpGaD
Ioflupane I 123—Dizziness—Paclitaxel—breast cancer	0.00113	0.00133	CcSEcCtD
Ioflupane I 123—SLC6A3—Neuronal System—KCNH1—breast cancer	0.00112	0.0088	CbGpPWpGaD
Ioflupane I 123—Malnutrition—Doxorubicin—breast cancer	0.00111	0.0013	CcSEcCtD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.00109	0.00859	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.00109	0.00859	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTA1—breast cancer	0.00109	0.00858	CbGpPWpGaD
Ioflupane I 123—Dysgeusia—Doxorubicin—breast cancer	0.00109	0.00128	CcSEcCtD
Ioflupane I 123—Vertigo—Epirubicin—breast cancer	0.00108	0.00127	CcSEcCtD
Ioflupane I 123—Headache—Paclitaxel—breast cancer	0.00107	0.00126	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Docetaxel—breast cancer	0.00107	0.00126	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Capecitabine—breast cancer	0.00104	0.00122	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Methotrexate—breast cancer	0.00103	0.00121	CcSEcCtD
Ioflupane I 123—Nausea—Paclitaxel—breast cancer	0.00102	0.0012	CcSEcCtD
Ioflupane I 123—Dry mouth—Epirubicin—breast cancer	0.000999	0.00117	CcSEcCtD
Ioflupane I 123—Vertigo—Doxorubicin—breast cancer	0.000997	0.00117	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Epirubicin—breast cancer	0.00096	0.00113	CcSEcCtD
Ioflupane I 123—Dizziness—Docetaxel—breast cancer	0.00096	0.00113	CcSEcCtD
Ioflupane I 123—SLC6A3—Monoamine Transport—IL1B—breast cancer	0.000943	0.0074	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000942	0.00739	CbGpPWpGaD
Ioflupane I 123—Paraesthesia—Methotrexate—breast cancer	0.000939	0.0011	CcSEcCtD
Ioflupane I 123—Dizziness—Capecitabine—breast cancer	0.000929	0.00109	CcSEcCtD
Ioflupane I 123—Dry mouth—Doxorubicin—breast cancer	0.000924	0.00109	CcSEcCtD
Ioflupane I 123—Headache—Docetaxel—breast cancer	0.000909	0.00107	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Methotrexate—breast cancer	0.000903	0.00106	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A2—breast cancer	0.0009	0.00706	CbGpPWpGaD
Ioflupane I 123—Pain—Methotrexate—breast cancer	0.000894	0.00105	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Doxorubicin—breast cancer	0.000888	0.00104	CcSEcCtD
Ioflupane I 123—Headache—Capecitabine—breast cancer	0.00088	0.00103	CcSEcCtD
Ioflupane I 123—Paraesthesia—Epirubicin—breast cancer	0.000879	0.00103	CcSEcCtD
Ioflupane I 123—Nausea—Docetaxel—breast cancer	0.000862	0.00101	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Epirubicin—breast cancer	0.000845	0.000993	CcSEcCtD
Ioflupane I 123—SLC6A3—Alpha-synuclein signaling—SRC—breast cancer	0.000841	0.0066	CbGpPWpGaD
Ioflupane I 123—Pain—Epirubicin—breast cancer	0.000837	0.000984	CcSEcCtD
Ioflupane I 123—Nausea—Capecitabine—breast cancer	0.000835	0.000981	CcSEcCtD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000834	0.00654	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—STAT3—breast cancer	0.000833	0.00653	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Parkinsons Disease Pathway—CASP3—breast cancer	0.00082	0.00644	CbGpPWpGaD
Ioflupane I 123—Paraesthesia—Doxorubicin—breast cancer	0.000813	0.000956	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—TGFB2—breast cancer	0.000786	0.00616	CbGpPWpGaD
Ioflupane I 123—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000782	0.000919	CcSEcCtD
Ioflupane I 123—Pain—Doxorubicin—breast cancer	0.000775	0.00091	CcSEcCtD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—TGFB1—breast cancer	0.000772	0.00606	CbGpPWpGaD
Ioflupane I 123—Hypersensitivity—Methotrexate—breast cancer	0.000771	0.000906	CcSEcCtD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000763	0.00598	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000763	0.00598	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SQSTM1—breast cancer	0.000743	0.00583	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC5A5—breast cancer	0.000721	0.00566	CbGpPWpGaD
Ioflupane I 123—Hypersensitivity—Epirubicin—breast cancer	0.000721	0.000848	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A1—breast cancer	0.000697	0.00547	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—NQO1—breast cancer	0.000697	0.00547	CbGpPWpGaD
Ioflupane I 123—Dizziness—Methotrexate—breast cancer	0.000692	0.000813	CcSEcCtD
Ioflupane I 123—SLC6A3—Monoamine Transport—TNF—breast cancer	0.000684	0.00537	CbGpPWpGaD
Ioflupane I 123—Hypersensitivity—Doxorubicin—breast cancer	0.000667	0.000784	CcSEcCtD
Ioflupane I 123—Headache—Methotrexate—breast cancer	0.000655	0.00077	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—HSP90AA1—breast cancer	0.000655	0.00514	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—ACHE—breast cancer	0.000652	0.00511	CbGpPWpGaD
Ioflupane I 123—Dizziness—Epirubicin—breast cancer	0.000647	0.000761	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—EGR1—breast cancer	0.000647	0.00508	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000632	0.00496	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—COX11—breast cancer	0.000632	0.00496	CbGpPWpGaD
Ioflupane I 123—Nausea—Methotrexate—breast cancer	0.000621	0.00073	CcSEcCtD
Ioflupane I 123—Headache—Epirubicin—breast cancer	0.000613	0.000721	CcSEcCtD
Ioflupane I 123—Dizziness—Doxorubicin—breast cancer	0.000599	0.000704	CcSEcCtD
Ioflupane I 123—Nausea—Epirubicin—breast cancer	0.000581	0.000683	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTP1—breast cancer	0.000581	0.00456	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—TGFBR2—breast cancer	0.000581	0.00456	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000578	0.00453	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—HMOX1—breast cancer	0.000573	0.0045	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—BCHE—breast cancer	0.000568	0.00445	CbGpPWpGaD
Ioflupane I 123—Headache—Doxorubicin—breast cancer	0.000567	0.000667	CcSEcCtD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000567	0.00445	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000556	0.00437	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000556	0.00437	CbGpPWpGaD
Ioflupane I 123—Nausea—Doxorubicin—breast cancer	0.000538	0.000632	CcSEcCtD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTM1—breast cancer	0.000534	0.00419	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—HGF—breast cancer	0.000534	0.00419	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—NRG1—breast cancer	0.000524	0.00411	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—ACHE—breast cancer	0.000499	0.00392	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000479	0.00376	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000455	0.00357	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—COMT—breast cancer	0.000454	0.00356	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000439	0.00345	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000438	0.00344	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—BCHE—breast cancer	0.000435	0.00341	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000407	0.0032	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—COMT—breast cancer	0.000348	0.00273	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000346	0.00272	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—BRAF—breast cancer	0.00029	0.00227	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000288	0.00226	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000282	0.00221	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—TFRC—breast cancer	0.000252	0.00197	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—MDM2—breast cancer	0.000243	0.0019	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000242	0.0019	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—RAF1—breast cancer	0.000242	0.0019	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000231	0.00181	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000223	0.00175	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—BRAF—breast cancer	0.000222	0.00174	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—TGFB1—breast cancer	0.000218	0.00171	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—ALB—breast cancer	0.000217	0.0017	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000204	0.0016	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—PLG—breast cancer	0.000199	0.00156	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—MDM2—breast cancer	0.000186	0.00146	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—RAF1—breast cancer	0.000185	0.00145	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000184	0.00144	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000176	0.00138	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—HRAS—breast cancer	0.000133	0.00105	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ALB—breast cancer	0.00011	0.000865	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—HRAS—breast cancer	0.000102	0.000801	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—RAF1—breast cancer	9.97e-05	0.000782	CbGpPWpGaD
